Display options
Cite
Defendenti C, Atzeni F, Croce AM, et al. Morphological distribution of μ chains and cd15 receptors in colorectal polyp and adenocarcinoma specimens. BMC Clin Pathol. 2013;13:8doi: 10.1186/1472-6890-13-8.
Defendenti, C., Atzeni, F., Croce, A. M., Mussani, E., Saibeni, S., Bollani, S., Grosso, S., Almasio, P. L., Bruno, S., & Sarzi-Puttini, P. (2013). Morphological distribution of μ chains and cd15 receptors in colorectal polyp and adenocarcinoma specimens. BMC clinical pathology, 138. https://doi.org/10.1186/1472-6890-13-8
Defendenti, Caterina, et al. "Morphological distribution of μ chains and cd15 receptors in colorectal polyp and adenocarcinoma specimens." BMC clinical pathology vol. 13 (2013): 8. doi: https://doi.org/10.1186/1472-6890-13-8
Defendenti C, Atzeni F, Croce AM, Mussani E, Saibeni S, Bollani S, Grosso S, Almasio PL, Bruno S, Sarzi-Puttini P. Morphological distribution of μ chains and cd15 receptors in colorectal polyp and adenocarcinoma specimens. BMC Clin Pathol. 2013 Mar 01;13:8. doi: 10.1186/1472-6890-13-8. PMID: 23448299; PMCID: PMC3637070.
Copy Download .nbib Format: NLM
Share it on

BMC Clin Pathol. 2013 Mar 01;13:8. doi: 10.1186/1472-6890-13-8.

Morphological distribution of μ chains and cd15 receptors in colorectal polyp and adenocarcinoma specimens.

BMC clinical pathology

Caterina Defendenti, Fabiola Atzeni, Anna Maria Croce, Elena Mussani, Simone Saibeni, Simona Bollani, Silvia Grosso, Piero Luigi Almasio, Savino Bruno, Piercarlo Sarzi-Puttini

Affiliations

  1. Laboratory Unit and Divisions of Fatebenefratelli Hospital, Milan, Italy. [email protected].

PMID: 23448299 PMCID: PMC3637070 DOI: 10.1186/1472-6890-13-8

Abstract

BACKGROUND: We have recently investigated the localisation of immunoglobulin-producing cells (IPCs) in inflamed intestinal tissue samples from patients with inflammatory bowel disease (IBD), and identified two main patterns of B lymphocyte infiltration: one characterised by the moderate strong stromal localisation of small B1 cell-like IgM+/CD79+/CD20-/CD21-/CD23-/CD5 ± IPCs, and the other by the peri-glandular localisation of IPCs with irregular nuclei that had surface markers specific for a B cell subset (IgM and CD79), but quantitative differences in their λ and κ chains. The same patients were also tested for CD15+ receptors, which were localised on inflammatory cell surfaces or in the crypts of the intestinal epithelium. CD15+ receptor distribution in inflamed tissues was limited to the cell structures. The aim of the study was to analyse variations in IPCs and CD15+ cell morphology or distribution in bowel biopsy specimens taken from patients with pre-malignant polyps or adenocarcinomas.

METHODS: IPCs were analysed by means of immunofluorescence using polyclonal goat anti-human μ chains. The pre-malignant polyp specimens were tested for B cell surface phenotype λ and κ chains, CD79, CD20, CD21 and CD23 using an immunoperoxidase method. CD15+ cells were evaluated using the immunoperoxidase method and monoclonal anti-CD15 IgM.

RESULTS: The study involved 14 patients (four with pre-malignant polyps and 10 with colorectal adenocarcinomas). The distribution of μ chains and CD15 markers varied in all of the biopsies, but delineated normal cell structures in the pre-malignant polyp specimens. B cell surface phenotype analysis of μ chain-positive cells identified a subset of CD79+/CD20-/CD21-/CD23- IPCs. The IPCs in certain areas showed the sporadic disintegration of inflammatory cell membranes or the accumulation of fluorescence in individual cells. IPC membrane disintegration was particularly marked in all of the adenocarcinoma samples, in which the CD15 markers also showed epithelial cell involvement. Furthermore, six of the ten adenocarcinoma samples had atypical and reorganised membranes that expressed an excess of both receptors and isolated small portions of tissue within the tumour.

CONCLUSION: The findings of this preliminary morphological study suggest the presence of membrane disintegration and remodelling mechanisms in the tumours. The newly-formed membranes expressed high concentrations of inflammatory cell receptors that can confer adhesive properties.

References

  1. Immunol Today. 1996 Oct;17(10):471-5 - PubMed
  2. J Cell Biochem. 1988 May;37(1):1-9 - PubMed
  3. BMC Immunol. 2011 Dec 30;12:71 - PubMed
  4. An Acad Bras Cienc. 2009 Sep;81(3):489-96 - PubMed
  5. Cancer Metastasis Rev. 1995 Dec;14(4):351-62 - PubMed
  6. Melanoma Res. 2003 Feb;13(1):11-8 - PubMed
  7. Cancer Sci. 2008 May;99(5):920-8 - PubMed
  8. Cancer Res. 1989 Dec 15;49(24 Pt 1):6883-8 - PubMed
  9. Nature. 2002 Dec 19-26;420(6917):860-7 - PubMed
  10. J Agric Food Chem. 2011 Oct 26;59(20):11304-18 - PubMed
  11. Acta Biochim Biophys Sin (Shanghai). 2011 Nov;43(11):840-8 - PubMed
  12. Neoplasia. 2011 Aug;13(8):685-91 - PubMed
  13. Cancer Cell. 2005 May;7(5):411-23 - PubMed
  14. Hum Immunol. 2009 May;70(5):325-30 - PubMed
  15. Pathol Res Pract. 2012 Jul 15;208(7):387-91 - PubMed
  16. Neoplasia. 1999 Nov;1(5):453-60 - PubMed
  17. J Exp Med. 1989 Jun 1;169(6):1869-77 - PubMed
  18. Am J Pathol. 1992 Dec;141(6):1397-408 - PubMed
  19. Int J Cancer. 1987 Jul 15;40(1):24-31 - PubMed
  20. Mol Cell Biochem. 1996 Sep 20;162(2):97-103 - PubMed

Publication Types